1. The current landscape of nucleic acid therapeutics;Kulkarni;Nat. Nanotechnol.,2021
2. S. Gottlieb, Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies, (2019). https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-peter-marks-md-phd-director-center-biologics (accessed January 10, 2023).
3. The delivery of therapeutic oligonucleotides;Juliano;Nucl. Acids Res.,2016
4. GalNAc-siRNA Conjugates: Leading the Way for delivery of RNAi therapeutics;Springer;Nucleic Acid Ther.,2018
5. Visualization of self-delivering hydrophobically modified siRNA cellular internalization;Ly;Nucleic Acids Res.,2017